NCT04004923

Intracranial Pressure in Monopolar and Bipolar Hysteroscopy

Name: Clinical Trial NCT04004923
Creator: Kanuni Sultan Suleyman Training and Research Hospital
Keywords: Intracranial Pressure Increase, Monopolar hysteroscopy, procedure, clinical trial, Turkey

Monopolar or Bipolar Hysteroscopy: Comparison of the Impact of Two Methods on Intracranial Pressure

Kanuni Sultan Suleyman Training and Research Hospital·ClinicalTrials.gov·procedureCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Intracranial Pressure Increase
Drug/Device/Intervention: Monopolar hysteroscopy
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: Kanuni Sultan Suleyman Training and Research Hospital
Location: Istanbul, Turkey

Timeline & enrollment

Phase: N/A
Start date: Jul 05, 2019
End date: Oct 30, 2019
Enrollment: 80 participants

Primary outcome

Intracranial pressure

Summary

Two distinction fluids are used in operative hysteroscopy. One is monopolar and the second is bipolar. The monopolar fluid contains mannitol and the bipolar fluid contains serum physiologic. This study aims to compare intracranial pressure in patients undergoing monopolar and bipolar hysteroscopy.

ICD-10 classifications

Benign intracranial hypertensionIntracranial injuryIntracranial injury, unspecifiedOther intracranial injuriesIntracranial hypotension following ventricular shunting

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT04004923
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT04004923 through Pure Global AI's free database. This phase not specified trial is sponsored by Kanuni Sultan Suleyman Training and Research Hospital and is currently Completed. The study focuses on Intracranial Pressure Increase. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.